Publications
2 shownNeoadjuvant PD-1 Blockade in Resectable Lung Cancer
Neoadjuvant nivolumab was associated with few side effects, did not delay surgery, and induced a major pathological response in 45% of resected tumors. The tumor mutational burd...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 6,219
- Institution
- Memorial Sloan Kettering Cancer Center
External Links
Identifiers
- ORCID
- 0000-0002-5838-9982
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.